Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma Group (MREO) Interest Coverage Ratio: 2023-2025

Historic Interest Coverage Ratio for Mereo BioPharma Group (MREO) over the last 3 years, with Sep 2025 value amounting to -357.68.

  • Mereo BioPharma Group's Interest Coverage Ratio fell 1247.07% to -357.68 in Q3 2025 from the same period last year, while for Sep 2025 it was -77.42, marking a year-over-year decrease of 165.91%. This contributed to the annual value of -34.57 for FY2024, which is 250.52% down from last year.
  • Per Mereo BioPharma Group's latest filing, its Interest Coverage Ratio stood at -357.68 for Q3 2025, which was up 18.24% from -437.46 recorded in Q2 2025.
  • Over the past 5 years, Mereo BioPharma Group's Interest Coverage Ratio peaked at -0.79 during Q2 2023, and registered a low of -437.46 during Q2 2025.
  • Over the past 3 years, Mereo BioPharma Group's median Interest Coverage Ratio value was -31.94 (recorded in 2024), while the average stood at -94.86.
  • Data for Mereo BioPharma Group's Interest Coverage Ratio shows a maximum YoY crashed of 4,811.92% (in 2024) over the last 5 years.
  • Over the past 3 years, Mereo BioPharma Group's Interest Coverage Ratio (Quarterly) stood at -20.19 in 2023, then plummeted by 101.72% to -40.73 in 2024, then plummeted by 1,247.07% to -357.68 in 2025.
  • Its Interest Coverage Ratio was -357.68 in Q3 2025, compared to -437.46 in Q2 2025 and -62.23 in Q1 2025.